Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in advanced pancreatic cancer
NCT00059982Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in pancreatic adenocarcinoma (PDAC), sponsored by Eastern Cooperative Oncology Group. Started Jul 2003; status: completed.
02
Drugs
perifosine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00059982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059982.